Structure

Physi-Chem Properties

Molecular Weight:  576.26
Volume:  597.067
LogP:  6.882
LogD:  3.955
LogS:  -7.358
# Rotatable Bonds:  2
TPSA:  63.63
# H-Bond Aceptor:  7
# H-Bond Donor:  1
# Rings:  8
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.247
Synthetic Accessibility Score:  5.794
Fsp3:  0.333
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.755
MDCK Permeability:  2.0571536879288033e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.89
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.517
30% Bioavailability (F30%):  0.974

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.383
Plasma Protein Binding (PPB):  78.6504135131836%
Volume Distribution (VD):  1.376
Pgp-substrate:  11.283672332763672%

ADMET: Metabolism

CYP1A2-inhibitor:  0.09
CYP1A2-substrate:  0.957
CYP2C19-inhibitor:  0.073
CYP2C19-substrate:  0.954
CYP2C9-inhibitor:  0.043
CYP2C9-substrate:  0.586
CYP2D6-inhibitor:  0.014
CYP2D6-substrate:  0.96
CYP3A4-inhibitor:  0.073
CYP3A4-substrate:  0.949

ADMET: Excretion

Clearance (CL):  8.969
Half-life (T1/2):  0.109

ADMET: Toxicity

hERG Blockers:  0.945
Human Hepatotoxicity (H-HT):  0.026
Drug-inuced Liver Injury (DILI):  0.384
AMES Toxicity:  0.165
Rat Oral Acute Toxicity:  0.351
Maximum Recommended Daily Dose:  0.996
Skin Sensitization:  0.62
Carcinogencity:  0.044
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.454

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC139783

Natural Product ID:  NPC139783
Common Name*:   Tiliacorine
IUPAC Name:   n.a.
Synonyms:   Tiliacorine
Standard InCHIKey:  DQIJJKSVYLLDQW-WUFINQPMSA-N
Standard InCHI:  InChI=1S/C36H36N2O5/c1-37-11-9-22-17-31-32-19-24(22)27(37)15-20-5-7-29(39)25(13-20)26-14-21(6-8-30(26)40-3)16-28-34-23(10-12-38(28)2)18-33(41-4)35(42-31)36(34)43-32/h5-8,13-14,17-19,27-28,39H,9-12,15-16H2,1-4H3/t27-,28+/m0/s1
SMILES:  COc1cc2CCN([C@H]3c2c2c1Oc1cc4CCN([C@H](c4cc1O2)Cc1cc(c2cc(C3)ccc2OC)c(O)cc1)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2017491
PubChem CID:   14527218
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO941 Tiliacora triandra Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[22418278]
NPO941 Tiliacora triandra Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT171 Cell Line MRC5 Homo sapiens IC50 = 3.87 ug.mL-1 PMID[480158]
NPT66 Individual Protein Acetylcholinesterase Electrophorus electricus Inhibition = 60.3 % PMID[480159]
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC = 3.1 ug.mL-1 PMID[480158]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 3.1 ug.mL-1 PMID[480158]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC = 6.2 ug.mL-1 PMID[480158]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC139783 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC65312
0.994 High Similarity NPC16357
0.994 High Similarity NPC302245
0.994 High Similarity NPC95426
0.9822 High Similarity NPC275680
0.9822 High Similarity NPC22115
0.9709 High Similarity NPC256124
0.9645 High Similarity NPC274716
0.9645 High Similarity NPC254441
0.9645 High Similarity NPC167116
0.9586 High Similarity NPC49075
0.9586 High Similarity NPC279228
0.9586 High Similarity NPC285931
0.9586 High Similarity NPC328155
0.9586 High Similarity NPC217748
0.9586 High Similarity NPC290582
0.9586 High Similarity NPC42663
0.9586 High Similarity NPC229373
0.9586 High Similarity NPC290005
0.9586 High Similarity NPC104196
0.9586 High Similarity NPC8836
0.9586 High Similarity NPC222661
0.9586 High Similarity NPC7715
0.9586 High Similarity NPC182052
0.9586 High Similarity NPC258657
0.9586 High Similarity NPC311973
0.9586 High Similarity NPC15414
0.9586 High Similarity NPC181796
0.9586 High Similarity NPC223690
0.9586 High Similarity NPC54654
0.9586 High Similarity NPC271013
0.9586 High Similarity NPC239824
0.9586 High Similarity NPC90998
0.9586 High Similarity NPC185639
0.9586 High Similarity NPC251735
0.9535 High Similarity NPC206900
0.9532 High Similarity NPC116465
0.9532 High Similarity NPC212237
0.9527 High Similarity NPC286119
0.9471 High Similarity NPC30779
0.9461 High Similarity NPC12424
0.9461 High Similarity NPC251580
0.9461 High Similarity NPC129518
0.9461 High Similarity NPC41376
0.9425 High Similarity NPC478093
0.9401 High Similarity NPC198498
0.9401 High Similarity NPC227060
0.9401 High Similarity NPC317145
0.9401 High Similarity NPC63646
0.9401 High Similarity NPC276890
0.9401 High Similarity NPC76682
0.9401 High Similarity NPC10908
0.9401 High Similarity NPC317439
0.9401 High Similarity NPC115284
0.9371 High Similarity NPC478091
0.9371 High Similarity NPC478092
0.9371 High Similarity NPC30182
0.9371 High Similarity NPC473589
0.9368 High Similarity NPC60295
0.9368 High Similarity NPC191132
0.9349 High Similarity NPC293093
0.931 High Similarity NPC82457
0.931 High Similarity NPC175890
0.931 High Similarity NPC274661
0.931 High Similarity NPC48490
0.931 High Similarity NPC11296
0.9278 High Similarity NPC254581
0.9205 High Similarity NPC24260
0.9191 High Similarity NPC302275
0.9186 High Similarity NPC239584
0.9128 High Similarity NPC475479
0.9128 High Similarity NPC243454
0.9086 High Similarity NPC47077
0.9086 High Similarity NPC14507
0.9023 High Similarity NPC73492
0.9023 High Similarity NPC299990
0.8939 High Similarity NPC85381
0.8935 High Similarity NPC256012
0.8935 High Similarity NPC240841
0.8935 High Similarity NPC317272
0.8935 High Similarity NPC13916
0.8935 High Similarity NPC268503
0.8935 High Similarity NPC264850
0.8935 High Similarity NPC250846
0.8935 High Similarity NPC42549
0.8933 High Similarity NPC41122
0.8933 High Similarity NPC318805
0.8901 High Similarity NPC475654
0.8876 High Similarity NPC24465
0.884 High Similarity NPC234318
0.883 High Similarity NPC204908
0.883 High Similarity NPC83198
0.8814 High Similarity NPC249996
0.8786 High Similarity NPC152680
0.8786 High Similarity NPC190783
0.8786 High Similarity NPC232386
0.8771 High Similarity NPC281581
0.8757 High Similarity NPC79402
0.8757 High Similarity NPC80759
0.875 High Similarity NPC257269
0.875 High Similarity NPC230276
0.875 High Similarity NPC195538
0.8743 High Similarity NPC247639
0.8743 High Similarity NPC25084
0.8743 High Similarity NPC38964
0.8728 High Similarity NPC239775
0.8722 High Similarity NPC473716
0.8722 High Similarity NPC475597
0.8701 High Similarity NPC476202
0.8698 High Similarity NPC235143
0.8698 High Similarity NPC205255
0.8698 High Similarity NPC230956
0.8698 High Similarity NPC271388
0.8698 High Similarity NPC119649
0.8693 High Similarity NPC40496
0.8693 High Similarity NPC119068
0.8671 High Similarity NPC168753
0.8671 High Similarity NPC118274
0.8639 High Similarity NPC221864
0.8621 High Similarity NPC108434
0.8621 High Similarity NPC475215
0.8557 High Similarity NPC82056
0.8555 High Similarity NPC474931
0.8555 High Similarity NPC306555
0.8555 High Similarity NPC145832
0.8555 High Similarity NPC81218
0.8555 High Similarity NPC158376
0.8555 High Similarity NPC12053
0.8555 High Similarity NPC117188
0.8555 High Similarity NPC205421
0.8538 High Similarity NPC60186
0.8514 High Similarity NPC10871
0.8488 Intermediate Similarity NPC475393
0.8483 Intermediate Similarity NPC474507
0.8475 Intermediate Similarity NPC241704
0.8462 Intermediate Similarity NPC204828
0.8462 Intermediate Similarity NPC207757
0.8462 Intermediate Similarity NPC193949
0.8462 Intermediate Similarity NPC39701
0.8462 Intermediate Similarity NPC172765
0.8462 Intermediate Similarity NPC295691
0.8462 Intermediate Similarity NPC54379
0.8462 Intermediate Similarity NPC110416
0.8462 Intermediate Similarity NPC189266
0.8462 Intermediate Similarity NPC469817
0.8462 Intermediate Similarity NPC5238
0.8462 Intermediate Similarity NPC249797
0.8462 Intermediate Similarity NPC127674
0.8462 Intermediate Similarity NPC278799
0.8462 Intermediate Similarity NPC2413
0.8462 Intermediate Similarity NPC123323
0.8462 Intermediate Similarity NPC276588
0.8462 Intermediate Similarity NPC184026
0.8439 Intermediate Similarity NPC196447
0.8439 Intermediate Similarity NPC78222
0.8439 Intermediate Similarity NPC212794
0.8439 Intermediate Similarity NPC96603
0.8439 Intermediate Similarity NPC477563
0.8439 Intermediate Similarity NPC13504
0.8439 Intermediate Similarity NPC306843
0.8439 Intermediate Similarity NPC253043
0.8439 Intermediate Similarity NPC136508
0.8391 Intermediate Similarity NPC223077
0.8391 Intermediate Similarity NPC56887
0.8391 Intermediate Similarity NPC193853
0.8382 Intermediate Similarity NPC324144
0.8382 Intermediate Similarity NPC1229
0.838 Intermediate Similarity NPC32154
0.8371 Intermediate Similarity NPC173416
0.8371 Intermediate Similarity NPC148709
0.8371 Intermediate Similarity NPC476577
0.8363 Intermediate Similarity NPC476572
0.8333 Intermediate Similarity NPC209377
0.8333 Intermediate Similarity NPC169743
0.827 Intermediate Similarity NPC476565
0.8266 Intermediate Similarity NPC166014
0.8266 Intermediate Similarity NPC27410
0.8263 Intermediate Similarity NPC51957
0.8263 Intermediate Similarity NPC476151
0.8263 Intermediate Similarity NPC476144
0.8263 Intermediate Similarity NPC106295
0.8263 Intermediate Similarity NPC16107
0.8263 Intermediate Similarity NPC210437
0.8258 Intermediate Similarity NPC66341
0.8258 Intermediate Similarity NPC477020
0.8258 Intermediate Similarity NPC192135
0.8251 Intermediate Similarity NPC57036
0.8249 Intermediate Similarity NPC109925
0.8246 Intermediate Similarity NPC325871
0.8246 Intermediate Similarity NPC99659
0.8239 Intermediate Similarity NPC204947
0.8225 Intermediate Similarity NPC151895
0.8225 Intermediate Similarity NPC88249
0.8225 Intermediate Similarity NPC220858
0.8225 Intermediate Similarity NPC97221
0.8225 Intermediate Similarity NPC192768
0.8222 Intermediate Similarity NPC114364
0.8222 Intermediate Similarity NPC320223
0.8216 Intermediate Similarity NPC223236
0.8216 Intermediate Similarity NPC259350

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC139783 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9586 High Similarity NPD8054 Approved
0.9586 High Similarity NPD8053 Approved
0.9401 High Similarity NPD8251 Approved
0.9401 High Similarity NPD8252 Approved
0.9401 High Similarity NPD8099 Discontinued
0.9345 High Similarity NPD8156 Discontinued
0.8693 High Similarity NPD8453 Clinical (unspecified phase)
0.8441 Intermediate Similarity NPD8095 Phase 1
0.8263 Intermediate Similarity NPD4584 Approved
0.8208 Intermediate Similarity NPD6788 Approved
0.8054 Intermediate Similarity NPD7906 Approved
0.7989 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7977 Intermediate Similarity NPD4773 Phase 2
0.7977 Intermediate Similarity NPD4772 Phase 2
0.7955 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7955 Intermediate Similarity NPD7833 Phase 2
0.7955 Intermediate Similarity NPD7831 Phase 2
0.7931 Intermediate Similarity NPD7298 Approved
0.7904 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7877 Intermediate Similarity NPD6071 Discontinued
0.7838 Intermediate Similarity NPD7311 Approved
0.7838 Intermediate Similarity NPD7312 Approved
0.7838 Intermediate Similarity NPD7313 Approved
0.7838 Intermediate Similarity NPD7310 Approved
0.7796 Intermediate Similarity NPD7309 Approved
0.7778 Intermediate Similarity NPD3051 Approved
0.7759 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD4578 Approved
0.7742 Intermediate Similarity NPD4577 Approved
0.7735 Intermediate Similarity NPD2970 Approved
0.7735 Intermediate Similarity NPD2969 Approved
0.7733 Intermediate Similarity NPD7447 Phase 1
0.7713 Intermediate Similarity NPD4663 Approved
0.7692 Intermediate Similarity NPD27 Approved
0.7692 Intermediate Similarity NPD2489 Approved
0.7688 Intermediate Similarity NPD7549 Discontinued
0.7667 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD2563 Approved
0.764 Intermediate Similarity NPD2560 Approved
0.7572 Intermediate Similarity NPD2420 Approved
0.7572 Intermediate Similarity NPD2421 Approved
0.7572 Intermediate Similarity NPD7213 Phase 3
0.7572 Intermediate Similarity NPD7212 Phase 2
0.7558 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD4055 Discovery
0.7529 Intermediate Similarity NPD1424 Approved
0.7529 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD4675 Approved
0.7514 Intermediate Similarity NPD4678 Approved
0.75 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2898 Approved
0.7473 Intermediate Similarity NPD5677 Discontinued
0.7443 Intermediate Similarity NPD6031 Approved
0.7443 Intermediate Similarity NPD6030 Approved
0.7414 Intermediate Similarity NPD7124 Phase 2
0.7414 Intermediate Similarity NPD3845 Phase 1
0.7405 Intermediate Similarity NPD4481 Phase 3
0.7391 Intermediate Similarity NPD4010 Discontinued
0.7386 Intermediate Similarity NPD6090 Discontinued
0.7371 Intermediate Similarity NPD7598 Phase 2
0.736 Intermediate Similarity NPD4017 Approved
0.7356 Intermediate Similarity NPD5241 Discontinued
0.7345 Intermediate Similarity NPD2122 Discontinued
0.7345 Intermediate Similarity NPD3640 Phase 3
0.7345 Intermediate Similarity NPD3639 Approved
0.7345 Intermediate Similarity NPD3641 Approved
0.7337 Intermediate Similarity NPD2494 Approved
0.7337 Intermediate Similarity NPD7802 Discontinued
0.7337 Intermediate Similarity NPD6107 Approved
0.7337 Intermediate Similarity NPD3452 Approved
0.7337 Intermediate Similarity NPD3450 Approved
0.7337 Intermediate Similarity NPD2493 Approved
0.7321 Intermediate Similarity NPD4474 Approved
0.7321 Intermediate Similarity NPD4475 Approved
0.731 Intermediate Similarity NPD2975 Approved
0.731 Intermediate Similarity NPD2974 Approved
0.731 Intermediate Similarity NPD2973 Approved
0.7309 Intermediate Similarity NPD8153 Approved
0.7309 Intermediate Similarity NPD8152 Approved
0.7293 Intermediate Similarity NPD5772 Approved
0.7293 Intermediate Similarity NPD5773 Approved
0.7287 Intermediate Similarity NPD42 Phase 2
0.7287 Intermediate Similarity NPD6042 Phase 2
0.7286 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6072 Discontinued
0.7268 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD4005 Discontinued
0.7251 Intermediate Similarity NPD6997 Phase 2
0.7241 Intermediate Similarity NPD5177 Phase 3
0.7236 Intermediate Similarity NPD3837 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD4123 Phase 3
0.7231 Intermediate Similarity NPD2488 Approved
0.7231 Intermediate Similarity NPD2490 Approved
0.7228 Intermediate Similarity NPD4582 Approved
0.7228 Intermediate Similarity NPD4583 Approved
0.7214 Intermediate Similarity NPD5005 Approved
0.7214 Intermediate Similarity NPD5006 Approved
0.7212 Intermediate Similarity NPD7047 Phase 3
0.72 Intermediate Similarity NPD4580 Approved
0.72 Intermediate Similarity NPD6748 Discontinued
0.7178 Intermediate Similarity NPD4002 Approved
0.7178 Intermediate Similarity NPD4004 Approved
0.7175 Intermediate Similarity NPD3124 Discontinued
0.7167 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD5718 Phase 2
0.7151 Intermediate Similarity NPD2200 Suspended
0.715 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD6666 Approved
0.7119 Intermediate Similarity NPD6667 Approved
0.7105 Intermediate Similarity NPD5312 Approved
0.7105 Intermediate Similarity NPD5313 Approved
0.7104 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD7466 Approved
0.7098 Intermediate Similarity NPD2968 Approved
0.7098 Intermediate Similarity NPD2971 Approved
0.7086 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD6851 Approved
0.7062 Intermediate Similarity NPD3692 Discontinued
0.7062 Intermediate Similarity NPD6853 Approved
0.7052 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD6621 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD4908 Phase 1
0.7041 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7031 Intermediate Similarity NPD6297 Approved
0.7022 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD4420 Approved
0.7 Intermediate Similarity NPD5602 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4625 Phase 3
0.6989 Remote Similarity NPD7037 Approved
0.6986 Remote Similarity NPD7827 Phase 1
0.6984 Remote Similarity NPD8051 Clinical (unspecified phase)
0.6982 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6979 Remote Similarity NPD7479 Phase 2
0.6977 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6977 Remote Similarity NPD2238 Phase 2
0.6977 Remote Similarity NPD1613 Approved
0.6971 Remote Similarity NPD1632 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6963 Remote Similarity NPD7493 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7590 Clinical (unspecified phase)
0.6961 Remote Similarity NPD5976 Discontinued
0.6959 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6959 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6954 Remote Similarity NPD6111 Discontinued
0.6954 Remote Similarity NPD6896 Approved
0.6954 Remote Similarity NPD6895 Approved
0.6952 Remote Similarity NPD5709 Phase 3
0.6949 Remote Similarity NPD4236 Phase 3
0.6949 Remote Similarity NPD4237 Approved
0.6949 Remote Similarity NPD3060 Approved
0.6944 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6931 Remote Similarity NPD4166 Phase 2
0.6927 Remote Similarity NPD4873 Discontinued
0.6927 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6919 Remote Similarity NPD4585 Approved
0.6915 Remote Similarity NPD4666 Phase 3
0.6914 Remote Similarity NPD1753 Discontinued
0.6911 Remote Similarity NPD5938 Phase 3
0.6906 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6902 Remote Similarity NPD5090 Approved
0.6902 Remote Similarity NPD7438 Suspended
0.6902 Remote Similarity NPD5089 Approved
0.6901 Remote Similarity NPD2669 Clinical (unspecified phase)
0.6898 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6893 Remote Similarity NPD4040 Phase 1
0.6884 Remote Similarity NPD7907 Approved
0.6881 Remote Similarity NPD6284 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7177 Discontinued
0.6872 Remote Similarity NPD2677 Approved
0.6869 Remote Similarity NPD7291 Discontinued
0.6868 Remote Similarity NPD7427 Discontinued
0.6854 Remote Similarity NPD4162 Approved
0.6851 Remote Similarity NPD7020 Approved
0.6851 Remote Similarity NPD7019 Approved
0.6845 Remote Similarity NPD7773 Phase 2
0.6839 Remote Similarity NPD5844 Phase 1
0.6836 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6836 Remote Similarity NPD7030 Discontinued
0.6828 Remote Similarity NPD2978 Approved
0.6828 Remote Similarity NPD2977 Approved
0.6825 Remote Similarity NPD2904 Discontinued
0.6821 Remote Similarity NPD7477 Discontinued
0.6816 Remote Similarity NPD6658 Clinical (unspecified phase)
0.6816 Remote Similarity NPD6331 Phase 2
0.6816 Remote Similarity NPD7125 Discontinued
0.6813 Remote Similarity NPD7526 Approved
0.6813 Remote Similarity NPD52 Approved
0.6813 Remote Similarity NPD3647 Clinical (unspecified phase)
0.6813 Remote Similarity NPD7527 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data